S3F Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Santhera Pharmaceuticals Holding AG

Watchlist Manager

Watchlist

Price: 13.64 EUR 1.64% Market Closed

Market Cap: €31.9m

S	Santhera Pharmaceuticals Holding AG F:S3F	CH
A	AstraZeneca PLC XMUN:ZEG	UK
P	Paychex Inc XMUN:PCX	US
F	Ford Motor Co F:FMC1	US
G	Grenergy Renovables SA XMUN:5GR	ES
	Anglo American Platinum Ltd OTC:ANGPY	ZA
N	Nikon Corp DUS:NKN	JP

Profitability Summary

Santhera Pharmaceuticals Holding AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

13%

Strong 3Y Average Gross Margin

59%

Declining Gross Margin

52% > 13%

Negative Operating Margin

-104%

Negative 3Y Average Operating Margin

-196%

Operating Margin is Increasing

-696% > -104%

Negative Net Margin

-134%

Negative 3Y Average Net Margin

-277%

Net Margin is Increasing

-951% > -134%

Negative Free Cash Flow Margin

-84%

Negative 3Y Average Free Cash Flow Margin

-155%

Free Cash Flow Margin is Increasing

-452% > -84%

Negative ROE

-136%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

ROIC is Increasing

-87% > -66%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.